Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview
Por:
Tabar, AI, Delgado, J, Gonzalez-Mancebo, E, Arroabarren, E, Retes, LS, Dominguez-Ortega, J
Publicada:
1 may 2021
Ahead of Print:
1 feb 2021
Resumen:
The Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and cost of the prolonged course of therapy in asthma. Thus, with the aim of clarifying some aspects with regard to the possible use of AIT in allergic asthma treatment armamentarium, a group of expert allergists from the Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), particularly from the Immunotherapy and Asthma Interest Groups developed a frequently asked questions in clinical practice. This document updates relevant topics on the use of AIT in asthma and could facilitate physician clinical decisions and improve health outcomes for individual patients.
Filiaciones:
Tabar, AI:
Hosp Complex Navarra, Dept Allergy, Pamplona, Spain
Navarra Inst Hlth Res IdiSNA, Cooperat Hlth Res Themat Networks RETICs Asthma A, Pamplona, Spain
Delgado, J:
Univ Hosp Virgen Macarena, Clin Management Allergy Unit, Seville, Spain
Gonzalez-Mancebo, E:
La Paz Hosp, Univ Hosp Fuenlabrada, Dept Allergy, Inst Hlth Res IdiPAZ, Madrid, Spain
Cooperat Hlth Res Themat Networks RETICs Asthma A, Madrid, Spain
Arroabarren, E:
Hosp Complex Navarra, Dept Allergy, Pamplona, Spain
Retes, LS:
Santa Creu & St Pau Hosp, Dept Pneumol & Allergy, Barcelona, Spain
Autonomous Univ Barcelona UAB, Dept Med, St Pau Biomed Res Inst IIB St Pau, Barcelona, Spain
Dominguez-Ortega, J:
La Paz Hosp, Dept Allergy, Inst Hlth Res IdiPAZ, CIBER Resp Dis,CIBERES, Madrid, Spain
Bronze
|